Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


Last €32.25 EUR
Change Today -0.97 / -2.91%
Volume 82.0
As of 3:48 PM 02/5/16 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

5301 Stevens Creek Boulevard

Santa Clara, CA 95051

United States

Phone: 408-345-8886

Fax: 408-345-8474

a given sample to enable further interrogation. Quantitative PCR or real time PCR is also a standard method used in genomic research facilities to measure the amount of a specific nucleic acid sequence within a sample. The company offers a portfolio of PCR & quantitative PCR instruments, as well as specialty enzymes for amplifying difficult sample types. In addition to PCR and quantitative PCR enzymes, the company offers a range of molecular biology reagents, including tools for cloning and mutagenesis applications. Nucleic Acid Solutions: The company’s Nucleic Acid Solutions division is a contract manufacturing and development services business with equipment and expertise focused on mid to large scale production of synthesized oligonucleotide APIs under pharmaceutical GMP conditions for an emerging class of drugs that utilize oligonucleotide molecules for disease therapy. Diagnostics and Genomics Customers The company had approximately 14,000 customers for its diagnostics and genomics business in fiscal 2015. Diagnostics and Genomics Sales, Marketing and Support The company deploys a multi-channel approach, marketing products to its customers through direct sales, electronic commerce, resellers, manufacturers' representatives and distributors. The company primarily uses direct sales to market its solutions to its pharmaceutical, biopharmaceutical and clinical accounts. Its active reseller program augments its ability to provide solutions to its customers. The company sells its consumable products through distributors, telesales, electronic commerce and direct sales. The company utilizes telesales for more mature product lines, as well as for reorders of reagent products. Competition The company’s principal competitors in the diagnostics and genomics arena include Roche Ventana Medical Systems, Inc., a member of the Roche Group; Leica Biosystems, Inc., a division of Danaher Corporation; Abbott Laboratories; Ilumina, Inc.; and Affymetrix, Inc. Diagnostics and Genomics Government Regulation During 2015, the company has made investments to address the issues identified in the FDA warning letter, lifted, received by its Glostrup, Denmark facility. Agilent CrossLab Business The Agilent CrossLab business spans the entire lab with its consumables and services portfolio, which is designed to improve customer outcomes. Key product categories in consumables include GC and LC columns, sample preparation products, custom chemistries, and a large selection of laboratory instrument supplies. Services include startup, operational, training and compliance support, as well as asset management and consultation services that help increase customer productivity. Custom service and consumable bundles are tailored to meet the specific application needs of various industries and to keep instruments fully operational and compliant with the respective industry requirements. Agilent CrossLab Markets The Pharmaceutical, Biotechnology, CRO & CMO Market: The company’s services and consumable products support customers in this market that consists of for-profit companies who participate across the pharmaceutical value chain in the areas of therapeutic research, discovery and development, clinical trials, manufacturing and quality assurance and quality control. The Life Science Research Market: The company’s services and consumable products support customers in this market that consists primarily of not-for-profit organizations and includes academic institutions, large government institutes and privately funded organizations. The Chemical and Energy Market: The natural gas and petroleum refining markets use the company’s services and consumable products to support their quality control and environmental safety reviews. The Environmental and Forensics Market: The company’s services and consumable products support the environmental industry customers that perform laboratory and field analysis of chemical pollutants in air, water, soil and solid waste. Environmental industry customers include all levels of government, the industrial and manufacturing sectors, engineering and consulting companies, commercial

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AG8:GR €32.25 EUR -0.97

AG8 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AMETEK Inc $45.33 USD -1.31
Analog Devices Inc $49.82 USD -1.85
NVIDIA Corp $26.43 USD -1.78
Sysmex Corp ¥7,570 JPY -170.00
Xilinx Inc $48.07 USD -1.29
View Industry Companies
 

Industry Analysis

AG8

Industry Average

Valuation AG8 Industry Range
Price/Earnings 27.6x
Price/Sales 3.0x
Price/Book 2.9x
Price/Cash Flow 29.9x
TEV/Sales 2.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact AGILENT TECHNOLOGIES INC, please visit www.agilent.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.